GE Healthcare Technologies Inc's stock fell 5.40% in pre-market trading on Wednesday, following the release of its first-quarter 2026 financial results.

The decline appears driven by the company's adjusted earnings per share of $0.99, which fell short of the IBES estimate of $1.05. Despite reporting revenue of $5,100 million that exceeded expectations of $5,037 million, investors reacted negatively to the earnings miss and the company's commentary on profitability pressures.

GE Healthcare noted that significant increases in memory chips, oil, and freight costs during the quarter are expected to impact the rest of 2026. The company acknowledged it is reducing its profit outlook, though it expects to offset more than half of the inflation impact through price adjustments and cost-saving actions. Additionally, profitability in the quarter was affected by a discrete supplier issue that has since been resolved.